Copyright
©The Author(s) 2019.
World J Gastroenterol. Feb 28, 2019; 25(8): 923-940
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.923
Published online Feb 28, 2019. doi: 10.3748/wjg.v25.i8.923
Characteristic | n = 76 | Proportion (%) | |
Gender | |||
Male | 64 | 84.21 | |
Female | 12 | 15.79 | |
Age (yr) | Median age 56 | ||
<60 | 52 | 68.42 | |
≥60 | 24 | 31.58 | |
Differentiation | |||
Well | 52 | 68.42 | |
Poor | 24 | 31.58 | |
Tumor size (cm) | |||
< 5 | 53 | 69.74 | |
≥ 5 | 23 | 30.26 | |
Lymph node metastasis | |||
Yes | 16 | 21.05 | |
No | 60 | 78.95 | |
HBV infection | |||
Yes | 41 | 53.95 | |
No | 35 | 46.05 | |
HCV infection | |||
Yes | 4 | 5.26 | |
No | 72 | 94.74 | |
Serum alpha-fetoprotein level (ng/mL) | |||
< 400 | 56 | 73.68 | |
≥ 400 | 20 | 26.32 |
- Citation: Hu YT, Li BF, Zhang PJ, Wu D, Li YY, Li ZW, Shen L, Dong B, Gao J, Zhu X. Dbx2 exhibits a tumor-promoting function in hepatocellular carcinoma cell lines via regulating Shh-Gli1 signaling. World J Gastroenterol 2019; 25(8): 923-940
- URL: https://www.wjgnet.com/1007-9327/full/v25/i8/923.htm
- DOI: https://dx.doi.org/10.3748/wjg.v25.i8.923